Medicare GLP-1 Bridge: eligibility, copay and current rules

Medicare’s GLP-1 Bridge is an active demonstration for eligible Part D beneficiaries, not universal coverage of every weight-loss prescription.

At a glance

CMS describes the demonstration from July 1, 2026 through December 31, 2027.
Eligibility and covered products require a current clinical review.
The $50 copay operates outside the usual Part D payment flow.

Check the demonstration before using an old coverage summary

The CMS overview describes a separate payment and prior-authorization process. Beneficiaries should use the current CMS or Medicare instructions and their clinician rather than assume a Part D plan must opt in.

Ordinary coverage for an approved indication can be a separate pathway. Ask which route applies to the exact prescription.

Sources: CMS: Medicare GLP-1 Bridge Medicare: GLP-1 Bridge patient eligibility

The current eligibility checkpoints

Medicare’s patient page requires qualifying prescription-drug coverage and age 18 or older. At treatment initiation, its listed thresholds are BMI at least 35; BMI at least 30 with specified heart failure, uncontrolled hypertension or stage 3a-or-higher kidney disease; or BMI at least 27 with prediabetes, previous heart attack or stroke, or symptomatic peripheral artery disease.

The demonstration excludes people already receiving GLP-1 coverage through Part D and lists type 2 diabetes, moderate-to-severe sleep apnea and fatty liver disease as exclusions; ordinary Part D coverage may be a separate route for those conditions. A prescription, applicable authorization and certification of a diet-and-exercise lifestyle program are also required. Use the Medicare eligibility tool with the clinician rather than self-certifying from a BMI number.

Sources: Medicare: GLP-1 Bridge patient eligibility

Understand what the copay does not do

CMS states the $50 eligible-drug copay does not count toward true out-of-pocket Part D spending. The deductible and low-income subsidy do not apply to those demonstration payments.

Clinical services or other expenses may still need separate consideration. Do not assume a compounded preparation or every dosage form is eligible.

Sources: CMS: Medicare GLP-1 Bridge Medicare: GLP-1 Bridge patient eligibility

Sources and review boundaries

Source check dates are listed below. First-party pages support descriptions of a service’s public offer; medical references support the educational context. They do not establish an independent clinical audit of a provider. This is general education, not personal medical advice; no named licensed clinical reviewer has reviewed this article.

CMS: Medicare GLP-1 BridgeMedical or regulatory source · Source reviewed · 2026-10-02
Medicare: GLP-1 Bridge patient eligibilityMedical or regulatory source · Source reviewed · 2026-10-02

By Chief Medical Correspondent. Published 2026-10-02. Updates are recorded when content changes.